Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance
Authors
Keywords
Inflammatory bowel disease, Cytokines, Mouse models, Colon, Inflammation, Gene expression, Cell proliferation, Weight loss
Journal
PLoS One
Volume 10, Issue 9, Pages e0135858
Publisher
Public Library of Science (PLoS)
Online
2015-09-12
DOI
10.1371/journal.pone.0135858
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin: Its emerging role in oncology
- (2014) Dragan Micic et al. Hormones-International Journal of Endocrinology and Metabolism
- Red Ginseng Extract Ameliorates Autoimmune Arthritis via Regulation of STAT3 Pathway, Th17/Treg Balance, and Osteoclastogenesis in Mice and Human
- (2014) JooYeon Jhun et al. MEDIATORS OF INFLAMMATION
- TGF-Beta Signaling Manipulation as Potential Therapy for IBD
- (2013) Irene Marafini et al. CURRENT DRUG TARGETS
- Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
- (2013) H. A. Hirsch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Th17 Cells
- (2012) Mohan S. Maddur et al. AMERICAN JOURNAL OF PATHOLOGY
- Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease
- (2012) Ali Raza et al. Expert Review of Clinical Immunology
- Identification of potent small-molecule inhibitors of STAT3 with anti-inflammatory properties in RAW 264.7 macrophages
- (2012) Hemachander Capiralla et al. FEBS Journal
- Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers
- (2012) Megan E. Himmel et al. IMMUNOLOGY
- Targeting IL-17 and TH17 cells in chronic inflammation
- (2012) Pierre Miossec et al. NATURE REVIEWS DRUG DISCOVERY
- Autoimmunity in 2010
- (2011) Carlo Selmi AUTOIMMUNITY REVIEWS
- Stat3 Phosphorylation Mediates Resistance of Primary Human T Cells to Regulatory T Cell Suppression
- (2011) W. A. Goodman et al. JOURNAL OF IMMUNOLOGY
- Zinc suppresses Th17 development via inhibition of STAT3 activation
- (2010) Chika Kitabayashi et al. INTERNATIONAL IMMUNOLOGY
- A Novel Mouse Model of Inflammatory Bowel Disease Links Mammalian Target of Rapamycin-Dependent Hyperproliferation of Colonic Epithelium to Inflammation-Associated Tumorigenesis
- (2009) Lin Deng et al. AMERICAN JOURNAL OF PATHOLOGY
- Foxp3+ Regulatory T Cells, Th17 Effector Cells, and Cytokine Environment in Inflammatory Bowel Disease
- (2009) Nicola Eastaff-Leung et al. JOURNAL OF CLINICAL IMMUNOLOGY
- VEGF-A Links Angiogenesis and Inflammation in Inflammatory Bowel Disease Pathogenesis
- (2008) Franco Scaldaferri et al. GASTROENTEROLOGY
- STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25− effector T cells
- (2008) Laura Passerini et al. INTERNATIONAL IMMUNOLOGY
- TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
- (2008) Liang Zhou et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now